BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 12069679)

  • 1. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer.
    Schwartz LM; Woloshin S
    JAMA; 2002 Jun; 287(23):3136-42. PubMed ID: 12069679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. News media coverage of a women's health contraversy: how newspapers and TV outlets covered a recent debate over screening mammography.
    Steele WR; Mebane F; Viswanath K; Solomon J
    Women Health; 2005; 41(3):83-97. PubMed ID: 15970577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolution of Mammography Controversy in the News Media: A Content Analysis of Four Publicized Screening Recommendations, 2009 to 2016.
    Nagler RH; Fowler EF; Marino NM; Mentzer KM; Gollust SE
    Womens Health Issues; 2019; 29(1):87-95. PubMed ID: 30409689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preserving scientific debate and patient choice: lessons from the Consensus Panel on Mammography Screening. National Institutes of Health.
    Woolf SH; Lawrence RS
    JAMA; 1997 Dec; 278(23):2105-8. PubMed ID: 9403427
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer screening among women younger than age 50: a current assessment of the issues.
    Smith RA
    CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Consensus Statement. Breast cancer screening for women ages 40-49.
    NIH Consens Statement; 1997 Jan 21-23; 15(1):1-35. PubMed ID: 9267441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening for women aged 40 through 49--a guidelines saga and a clarion call for informed decision making.
    Ernster VL
    Am J Public Health; 1997 Jul; 87(7):1103-6. PubMed ID: 9240097
    [No Abstract]   [Full Text] [Related]  

  • 10. Tamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control study.
    Cuzick J; Warwick J; Pinney E; Duffy SW; Cawthorn S; Howell A; Forbes JF; Warren RM
    J Natl Cancer Inst; 2011 May; 103(9):744-52. PubMed ID: 21483019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. US news media coverage of tobacco control issues.
    Long M; Slater MD; Lysengen L
    Tob Control; 2006 Oct; 15(5):367-72. PubMed ID: 16998170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccine and the news media, 1987-2001.
    Danovaro-Holliday MC; Wood AL; LeBaron CW
    JAMA; 2002 Mar; 287(11):1455-62. PubMed ID: 11903035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of Potential Harms and Benefits of Tamoxifen among Women Considering Breast Cancer Preventive Therapy.
    Thorneloe RJ; Hall LH; Walter FM; Side L; Lloyd KE; Smith SG;
    Cancer Prev Res (Phila); 2020 Apr; 13(4):411-422. PubMed ID: 31988145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reluctance toward tamoxifen use for breast cancer primary prevention.
    Port ER; Montgomery LL; Heerdt AS; Borgen PI
    Ann Surg Oncol; 2001 Aug; 8(7):580-5. PubMed ID: 11508619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis.
    Chapman S; McLeod K; Wakefield M; Holding S
    Med J Aust; 2005 Sep; 183(5):247-50. PubMed ID: 16138798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
    Metcalfe KA; Birenbaum-Carmeli D; Lubinski J; Gronwald J; Lynch H; Moller P; Ghadirian P; Foulkes WD; Klijn J; Friedman E; Kim-Sing C; Ainsworth P; Rosen B; Domchek S; Wagner T; Tung N; Manoukian S; Couch F; Sun P; Narod SA;
    Int J Cancer; 2008 May; 122(9):2017-22. PubMed ID: 18196574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. News media coverage of human papillomavirus.
    Anhang R; Stryker JE; Wright TC; Goldie SJ
    Cancer; 2004 Jan; 100(2):308-14. PubMed ID: 14716765
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.